The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

In adult mammals, massive sudden loss of cardiomyocytes after infarction overwhelms the limited regenerative capacity of the myocardium, resulting in the formation of a collagen-based scar. Necrotic cells release danger signals, activating innate immune pathways and triggering an intense inflammatory response. Stimulation of toll-like receptor signaling and complement activation induces expression of proinflammatory cytokines (such as interleukin-1 and tumor necrosis factor-α) and chemokines (such as monocyte chemoattractant protein-1/ chemokine (C-C motif) ligand 2 [CCL2]). Inflammatory signals promote adhesive interactions between leukocytes and endothelial cells, leading to extravasation of neutrophils and monocytes. As infiltrating leukocytes clear the infarct from dead cells, mediators repressing inflammation are released, and anti-inflammatory mononuclear cell subsets predominate. Suppression of the inflammatory response is associated with activation of reparative cells. Fibroblasts proliferate, undergo myofibroblast transdifferentiation, and deposit large amounts of extracellular matrix proteins maintaining the structural integrity of the infarcted ventricle. The renin-angiotensin-aldosterone system and members of the transforming growth factor-β family play an important role in activation of infarct myofibroblasts. Maturation of the scar follows, as a network of cross-linked collagenous matrix is formed and granulation tissue cells become apoptotic. This review discusses the cellular effectors and molecular signals regulating the inflammatory and reparative response after myocardial infarction. Dysregulation of immune pathways, impaired suppression of postinfarction inflammation, perturbed spatial containment of the inflammatory response, and overactive fibrosis may cause adverse remodeling in patients with infarction contributing to the pathogenesis of heart failure. Therapeutic modulation of the inflammatory and reparative response may hold promise for the prevention of postinfarction heart failure.

[1]  N. Frangogiannis.  Inflammation in cardiac injury, repair and regeneration , 2015, Current opinion in cardiology.

[2]  Z. Yang,et al.  Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. , 2000, Circulation.

[3]  P. Doevendans,et al.  Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .

[4]  H. Drexler,et al.  Continuous Glycoprotein-130-Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction , 2010, Circulation.

[5]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[6]  C. von Kalle,et al.  Bone marrow-derived cells contribute to infarct remodelling. , 2006, Cardiovascular research.

[7]  M. Entman,et al.  The role of platelet-derived growth factor signaling in healing myocardial infarcts. , 2006, Journal of the American College of Cardiology.

[8]  G. Parodi,et al.  Left Ventricular Remodeling and Heart Failure in Diabetic Patients Treated With Primary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.

[9]  S. Prabhu,et al.  Integrative Physiology Methods and Results: We Evaluated C57bl/6 Mice with Chronic Hf 8 Weeks after Coronary Ligation. as Compared with Sham-operated Controls, Hf Mice Exhibited: (1) Increased Proinflammatory Cd11b , 2022 .

[10]  G. Boivin,et al.  Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. , 2005, American journal of physiology. Heart and circulatory physiology.

[11]  K. Chatila,et al.  Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. , 2008, The American journal of pathology.

[12]  T. Noda,et al.  Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury , 2011, Circulation.

[13]  S. Müller,et al.  Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation , 2005, Circulation research.

[14]  M. Böhm,et al.  Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. , 2012, European heart journal.

[15]  M. Medvedovic,et al.  NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning. , 2010, Journal of molecular and cellular cardiology.

[16]  L. Liaudet,et al.  Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. , 2011, Cardiovascular research.

[17]  P. Koolwijk,et al.  Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction. , 2014, Journal of molecular and cellular cardiology.

[18]  G. Freeman,et al.  Induction of nuclear factor κB and activation protein 1 in postischemic myocardium , 1997, FEBS letters.

[19]  M. Entman,et al.  Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts , 2005, The Journal of pathology.

[20]  M. E. Ritchie.  Nuclear Factor-κB Is Selectively and Markedly Activated in Humans With Unstable Angina Pectoris , 1998 .

[21]  M. Taniguchi,et al.  Activation of Natural Killer T Cells Ameliorates Postinfarct Cardiac Remodeling and Failure in Mice , 2012, Circulation research.

[22]  B. Rollins,et al.  CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts , 2005, Circulation research.

[23]  J. Berman,et al.  Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. , 2002, Journal of molecular and cellular cardiology.

[24]  B. V. Van Tassell,et al.  Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. , 2014, Journal of the American College of Cardiology.

[25]  Jianling Xie,et al.  Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.

[26]  Guofeng Ren,et al.  Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling , 2007, Circulation.

[27]  K. Shimamoto,et al.  Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[28]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2010, Nature.

[29]  M. Seishima,et al.  Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. , 2002, Journal of the American College of Cardiology.

[30]  Ruhang Tang,et al.  Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling. , 2013, American journal of physiology. Heart and circulatory physiology.

[31]  V. Richard,et al.  Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[32]  G. Pasterkamp,et al.  Innate immune signaling in cardiac ischemia , 2011, Nature Reviews Cardiology.

[33]  I. Kubota,et al.  High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction. , 2015, Journal of atherosclerosis and thrombosis.

[34]  V. Chopra,et al.  Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. , 2011, The American journal of medicine.

[35]  J. Leor,et al.  Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. , 2000, Journal of molecular and cellular cardiology.

[36]  J. Kalbfleisch,et al.  CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling. , 2013, Biochimica et biophysica acta.

[37]  C. Weber,et al.  Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype , 2016, European heart journal.

[38]  H. Ogawa,et al.  The extra domain A of fibronectin stimulates murine mast cells via Toll‐like receptor 4 , 2007, Journal of leukocyte biology.

[39]  H. Simon,et al.  Living and dying for inflammation: neutrophils, eosinophils, basophils. , 2013, Trends in immunology.

[40]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[41]  J. Tardif,et al.  Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. , 2013, Journal of the American College of Cardiology.

[42]  Joseph A. Hill,et al.  Abstract 261: Foxo4 Promotes Early Inflammatory Response Upon Myocardial Infarction via Endothelial Arg1 , 2015 .

[43]  A. Itai,et al.  Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury , 2004 .

[44]  D. Mann.  Innate immunity and the failing heart: the cytokine hypothesis revisited. , 2015, Circulation research.

[45]  L. Brown,et al.  VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. , 1996, The American journal of physiology.

[46]  G. Pasterkamp,et al.  The innate immune response in reperfused myocardium. , 2012, Cardiovascular research.

[47]  M. Hiroe,et al.  Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. , 2010, American journal of physiology. Heart and circulatory physiology.

[48]  Yu Lin,et al.  Resolvin E1 protects the rat heart against reperfusion injury. , 2010, American journal of physiology. Heart and circulatory physiology.

[49]  N. Frangogiannis,et al.  Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. , 2016, Translational research : the journal of laboratory and clinical medicine.

[50]  M. Entman,et al.  Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). , 2000, Cardiovascular research.

[51]  J. Oyama,et al.  Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice , 2003, Circulation.

[52]  J. Hewitson,et al.  The adult murine heart has a sparse, phagocytically active macrophage population that expands through monocyte recruitment and adopts an ‘M2’ phenotype in response to Th2 immunologic challenge , 2015, Immunobiology.

[53]  Ajai Kumar Jain,et al.  PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial , 2007 .

[54]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  F. Geissmann,et al.  The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C− monocytes , 2011, Nature Immunology.

[56]  Gerard Pasterkamp,et al.  Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction , 2011, Circulation research.

[57]  N. Frangogiannis,et al.  Targeting inflammatory pathways in myocardial infarction , 2013, European journal of clinical investigation.

[58]  J. Lessick,et al.  Impact of Diastolic Dysfunction on the Development of Heart Failure in Diabetic Patients After Acute Myocardial Infarction , 2010, Circulation. Heart failure.

[59]  E. Topol,et al.  Myeloperoxidase-Generated Oxidants Modulate Left Ventricular Remodeling but Not Infarct Size After Myocardial Infarction , 2005, Circulation.

[60]  N. Frangogiannis,et al.  The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.

[61]  R. Gibbons,et al.  Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study , 2001, Circulation.

[62]  M. Entman,et al.  Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. , 1993, The Journal of clinical investigation.

[63]  C. Vergely,et al.  Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse. , 2015, Clinical science.

[64]  Stephanie L. K. Bowers,et al.  Cardiac Fibroblast: The Renaissance Cell , 2009, Circulation research.

[65]  Sumanth D. Prabhu,et al.  Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction , 2014, Basic Research in Cardiology.

[66]  L. Varani,et al.  HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 , 2012, The Journal of experimental medicine.

[67]  M. Gyöngyösi,et al.  Inflammation and postinfarct remodeling: overexpression of IkappaB prevents ventricular dilation via increasing TIMP levels. , 2006, Cardiovascular research.

[68]  G. Dorn,et al.  Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling , 2007 .

[69]  S. Butz,et al.  GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice , 2011, Nature Medicine.

[70]  N. Frangogiannis,et al.  Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix Metabolism , 2011, Hypertension.

[71]  N. Khaper,et al.  Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.

[72]  Gerard Pasterkamp,et al.  Targeted Deletion of Nuclear Factor &kgr;B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction , 2009, Circulation research.

[73]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[74]  A. Ogata,et al.  Hypoxic stress induces cardiac myocyte-derived interleukin-6. , 1995, Circulation.

[75]  Osamu Takeuchi,et al.  Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction , 2002, Circulation.

[76]  W. Greene,et al.  Shaping the nuclear action of NF-kappaB. , 2004, Nature reviews. Molecular cell biology.

[77]  M. Entman,et al.  Induction and suppression of interferon‐inducible protein (IP)‐10 in reperfused myocardial infarcts may regulate angiogenesis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[78]  Yao Sun,et al.  Platelet-derived growth factor involvement in myocardial remodeling following infarction. , 2011, Journal of molecular and cellular cardiology.

[79]  S. Prabhu.  Cytokine-Induced Modulation of Cardiac Function , 2004, Circulation research.

[80]  G. Pasterkamp,et al.  Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs , 2012, Circulation. Cardiovascular interventions.

[81]  A. Geinoz,et al.  The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, Journal of Cell Biology.

[82]  Mark E. Anderson,et al.  MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. , 2012, Journal of molecular and cellular cardiology.

[83]  R. Fandrich,et al.  High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling , 2014, PloS one.

[84]  E. Hirsch,et al.  Myocyte signalling in leucocyte recruitment to the heart. , 2014, Cardiovascular research.

[85]  N. Frangogiannis,et al.  CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans. , 2014, Cardiovascular research.

[86]  D. Tsiantoulas,et al.  B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction , 2013, Nature Medicine.

[87]  M. Giacca,et al.  Gene Transfer of IκBα Limits Infarct Size in a Mouse Model of Myocardial Ischemia-Reperfusion Injury , 2003, Laboratory Investigation.

[88]  W. Kuziel,et al.  CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[89]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[90]  LixiaYue,et al.  TRPM7-Mediated Ca2+ Signals Confer Fibrogenesis in Human Atrial Fibrillation , 2010 .

[91]  Hiroyuki Tsutsui,et al.  Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. , 2004, Cardiovascular research.

[92]  L. Birnbaumer,et al.  A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. , 2012, Developmental cell.

[93]  C. Mackay,et al.  Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. , 1997, Circulation.

[94]  N. Frangogiannis,et al.  The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. , 2010, Journal of molecular and cellular cardiology.

[95]  Z. Haque,et al.  The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction. , 2015, Journal of molecular and cellular cardiology.

[96]  A. J. Valente,et al.  Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury* , 2009, Journal of Biological Chemistry.

[97]  Keiichi Fukuda,et al.  Deleterious Effect of the IL-23/IL-17A Axis and γδT Cells on Left Ventricular Remodeling After Myocardial Infarction , 2012, Journal of the American Heart Association.

[98]  Stephane Heymans,et al.  Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity , 2014, Circulation research.

[99]  N. Frangogiannis,et al.  IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium , 2013, The Journal of Immunology.

[100]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[101]  M. Goumans,et al.  Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction , 2008, Circulation research.

[102]  Xiangru Lu,et al.  Cardiomyocyte-Specific Overexpression of Human Stem Cell Factor Improves Cardiac Function and Survival After Myocardial Infarction in Mice , 2009, Circulation.

[103]  P. Libby,et al.  Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. , 2008, American heart journal.

[104]  M. Yacoub,et al.  Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart , 2008, Circulation.

[105]  M. Lindsey,et al.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. , 1998, Circulation.

[106]  D. Mann.  The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. , 2011, Circulation research.

[107]  D. Mann,et al.  Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. , 2010, American journal of physiology. Heart and circulatory physiology.

[108]  A. Tager,et al.  Induction of the CXC Chemokine Interferon-&ggr;–Inducible Protein 10 Regulates the Reparative Response Following Myocardial Infarction , 2009, Circulation research.

[109]  M. Entman,et al.  Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. , 2007, Cardiovascular research.

[110]  De-Pei Liu,et al.  Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction , 2007, Circulation.

[111]  P. Schneider,et al.  Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction , 2015, The Journal of Immunology.

[112]  Samantha A. Tavener,et al.  Immune Cell Toll-Like Receptor 4 Is Required for Cardiac Myocyte Impairment During Endotoxemia , 2004, Circulation research.

[113]  M. Beltrame,et al.  Upwardly mobile proteins , 2000, EMBO reports.

[114]  P. Pibarot,et al.  Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. , 2010, Journal of the American College of Cardiology.

[115]  David L. Williams,et al.  Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. , 2008, Cardiovascular research.

[116]  Qiang-sun Zheng,et al.  Chymase induces profibrotic response via transforming growth factor-β1/Smad activation in rat cardiac fibroblasts , 2008, Molecular and Cellular Biochemistry.

[117]  S. Kostin,et al.  Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart , 2015, Nature Medicine.

[118]  B. Funke,et al.  High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart , 2008, Circulation.

[119]  K. Fukuda,et al.  Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. , 2013, Journal of molecular and cellular cardiology.

[120]  S. Akira,et al.  Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. , 2007, American journal of physiology. Heart and circulatory physiology.

[121]  David L. Williams,et al.  TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. , 2010, Cardiovascular research.

[122]  R. Bolli,et al.  Nuclear Factor- (cid:107) B Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits , 2022 .

[123]  S. Gerondakis,et al.  The FASEB Journal • FJ Express Full-Length Article Absence of NF-�B subunit p50 improves heart failure after myocardial infarction , 2022 .

[124]  Ansuman T. Satpathy,et al.  Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. , 2014, Immunity.

[125]  Adeline Koh,et al.  Osteopontin Expression Is Required for Myofibroblast Differentiation , 2008, Circulation research.

[126]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[127]  W. Nacken,et al.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.

[128]  M. Boerries,et al.  S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4 , 2014, EMBO molecular medicine.

[129]  E. Kardami,et al.  Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[130]  K. Tobita,et al.  Human Pericytes for Ischemic Heart Repair , 2013, Stem cells.

[131]  R. Medzhitov,et al.  Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. , 1999, The Journal of clinical investigation.

[132]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[133]  James W. Smyth,et al.  Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction , 2008, Circulation.

[134]  O. Soehnlein,et al.  Phagocyte partnership during the onset and resolution of inflammation , 2010, Nature Reviews Immunology.

[135]  M. Penn,et al.  SDF-1 in myocardial repair , 2012, Gene Therapy.

[136]  R. V. van Leeuwen,et al.  Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening , 2015, Circulation research.

[137]  I. Kubota,et al.  High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. , 2008, Cardiovascular research.

[138]  G. Newton,et al.  Emerging mechanisms of neutrophil recruitment across endothelium. , 2011, Trends in immunology.

[139]  B. Chandrasekar,et al.  Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo , 2011, Basic Research in Cardiology.

[140]  Daniel G. Anderson,et al.  In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. , 2013, Journal of the American College of Cardiology.

[141]  M. Taniguchi,et al.  Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice. , 2013, Journal of molecular and cellular cardiology.

[142]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[143]  Ruhang Tang,et al.  IKKβ inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury , 2007 .

[144]  S. Paruchuri,et al.  A TRP to cardiac fibroblast differentiation , 2013, Channels.

[145]  G. Rabinovich,et al.  Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. , 2013, The American journal of pathology.

[146]  J. Vicencio,et al.  Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis , 2013, Basic Research in Cardiology.

[147]  L. Wallentin,et al.  Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. , 2007, European heart journal.

[148]  A. Zernecke,et al.  A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. , 2010, Journal of the American College of Cardiology.

[149]  W. Kuziel,et al.  Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. , 2004, The American journal of pathology.

[150]  N. Turner,et al.  Function and fate of myofibroblasts after myocardial infarction , 2013, Fibrogenesis & tissue repair.

[151]  M. Scherrer-Crosbie,et al.  Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. , 2008, American journal of physiology. Heart and circulatory physiology.

[152]  K. Weber,et al.  Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. , 1996, Journal of molecular and cellular cardiology.

[153]  G. Biondi-Zoccai,et al.  Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). , 2010, The American journal of cardiology.

[154]  D. Greaves,et al.  CC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological Challenges , 2013, Pharmacological Reviews.

[155]  W. Greene,et al.  Shaping the nuclear action of NF-κB , 2004, Nature Reviews Molecular Cell Biology.

[156]  L. Kirshenbaum,et al.  Multiple facets of NF-κB in the heart: to be or not to NF-κB. , 2011, Circulation Research.

[157]  T. Horie,et al.  Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. , 2001, American journal of respiratory and critical care medicine.

[158]  S. Akira,et al.  Stat3 in Resident Macrophages as a Repressor Protein of Inflammatory Response1 , 2005, The Journal of Immunology.

[159]  M. Entman,et al.  Extracellular matrix remodeling in canine and mouse myocardial infarcts , 2006, Cell and Tissue Research.

[160]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[161]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[162]  D. Webb,et al.  Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. , 1998, Circulation.

[163]  M. Entman,et al.  Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. , 1999, Circulation.

[164]  P. Libby,et al.  Targeting Interleukin-1&bgr; Reduces Leukocyte Production After Acute Myocardial Infarction , 2015, Circulation.

[165]  Merry L. Lindsey,et al.  IL-10 Is Induced in the Reperfused Myocardium and May Modulate the Reaction to Injury1 , 2000, The Journal of Immunology.

[166]  M. E. Ritchie.  Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. , 1998, Circulation.

[167]  M. Fukayama,et al.  Periostin is essential for cardiac healing after acute myocardial infarction , 2008 .

[168]  C. Tschöpe,et al.  Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice1 , 2008, The Journal of Immunology.

[169]  V. Dixit,et al.  Signaling in innate immunity and inflammation. , 2012, Cold Spring Harbor perspectives in biology.

[170]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[171]  T. Guo,et al.  Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. , 2010, American journal of physiology. Heart and circulatory physiology.

[172]  S. Pedersen,et al.  Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction. , 2011, JACC. Cardiovascular interventions.

[173]  G. Pasterkamp,et al.  Danger Signals in the Initiation of the Inflammatory Response after Myocardial Infarction , 2013, Mediators of inflammation.

[174]  R. Weissleder,et al.  Differential Contribution of Monocytes to Heart Macrophages in Steady-State and After Myocardial Infarction , 2014, Circulation research.

[175]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[176]  Dong I. Lee,et al.  Cardiomyocyte-Specific Transforming Growth Factor &bgr; Suppression Blocks Neutrophil Infiltration, Augments Multiple Cytoprotective Cascades, and Reduces Early Mortality After Myocardial Infarction , 2014, Circulation research.

[177]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[178]  M. Chiariello,et al.  Increased high mobility group box-1 protein levels are associated with impaired cardiopulmonary and echocardiographic findings after acute myocardial infarction. , 2009, Journal of cardiac failure.

[179]  T. Edvardsen,et al.  Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury. , 2011, American journal of physiology. Heart and circulatory physiology.

[180]  A. M. Lefer,et al.  In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. , 1993, The Journal of clinical investigation.

[181]  A. Sato,et al.  Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[182]  M. Andrassy,et al.  S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling , 2012, Basic Research in Cardiology.

[183]  N. Frangogiannis.  The reparative function of cardiomyocytes in the infarcted myocardium. , 2015, Cell metabolism.

[184]  H. Broxmeyer,et al.  SDF‐1/CXCL12 Enhances Survival and Chemotaxis of Murine Embryonic Stem Cells and Production of Primitive and Definitive Hematopoietic Progenitor Cells , 2005, Stem cells.

[185]  A. Desmoulière,et al.  The Myofibroblast: one function, multiple origins , 2010 .

[186]  Yongwei Yao,et al.  Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. , 2011, American journal of physiology. Heart and circulatory physiology.

[187]  V. Hasselblad,et al.  Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. , 2013, International journal of cardiology.

[188]  G. Wang,et al.  Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-&kgr;B and Inflammatory Activation , 2009, Circulation.

[189]  F. D’Acquisto,et al.  Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo , 2012, The Journal of experimental medicine.

[190]  S. Gerondakis,et al.  Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. , 2007, The American journal of pathology.

[191]  N. Rosenthal,et al.  Revisiting Cardiac Cellular Composition. , 2016, Circulation research.

[192]  N. Frangogiannis,et al.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[193]  Y. Okada,et al.  Regulatory Role of Dendritic Cells in Postinfarction Healing and Left Ventricular Remodeling , 2012, Circulation.

[194]  S. Yamada,et al.  Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. , 2008, Cardiovascular research.

[195]  N. Rosenthal,et al.  An Abundant Tissue Macrophage Population in the Adult Murine Heart with a Distinct Alternatively-Activated Macrophage Profile , 2012, PloS one.

[196]  Douglas Losordo,et al.  Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. , 2010, Journal of the American College of Cardiology.

[197]  E. Leof,et al.  The FASEB Journal • Research Communication Imatinib mesylate blocks a non-Smad TGF- � pathway and reduces renal fibrogenesis in vivo , 2022 .

[198]  J. Kalbfleisch,et al.  Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury. , 2014, Biochimica et biophysica acta.

[199]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[200]  W. Chao.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. , 2009, American journal of physiology. Heart and circulatory physiology.

[201]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[202]  N. Frangogiannis,et al.  Endogenous IRAK-M Attenuates Postinfarction Remodeling Through Effects on Macrophages and Fibroblasts , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[203]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[204]  M. Giacca,et al.  Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury. , 2003, Laboratory investigation; a journal of technical methods and pathology.

[205]  E. Olson,et al.  Macrophages are required for neonatal heart regeneration. , 2014, The Journal of clinical investigation.

[206]  M. Pittet,et al.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. , 2010, Circulation.

[207]  S. Homma,et al.  Enhanced Efferocytosis of Apoptotic Cardiomyocytes Through Myeloid-Epithelial-Reproductive Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction , 2013, Circulation research.

[208]  P. Libby,et al.  Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis , 2012, The Journal of experimental medicine.

[209]  S. Paruchuri,et al.  TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. , 2013, Journal of molecular and cellular cardiology.

[210]  M. Daemen,et al.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.

[211]  N. Frangogiannis,et al.  Targeting the chemokines in cardiac repair. , 2014, Current pharmaceutical design.

[212]  P. Libby,et al.  Chigh Monocytes Depend on Nr 4 a 1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium , 2014 .

[213]  S. Prabhu,et al.  Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. , 2011, Cardiovascular research.

[214]  K. Chatila,et al.  CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.

[215]  N. Frangogiannis.  Matricellular proteins in cardiac adaptation and disease. , 2012, Physiological reviews.

[216]  G. Ertl,et al.  Activation of CD4+ T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice , 2012, Circulation.

[217]  S. Prabhu.  Post-infarction ventricular remodeling: an array of molecular events. , 2005, Journal of molecular and cellular cardiology.

[218]  Ruhang Tang,et al.  IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. , 2007, American journal of physiology. Heart and circulatory physiology.

[219]  N. Frangogiannis,et al.  Fibroblasts in myocardial infarction: a role in inflammation and repair. , 2014, Journal of molecular and cellular cardiology.

[220]  Hong Jiang,et al.  Preconditioning with high mobility group box 1 protein protects against myocardial ischemia–reperfusion injury , 2009, International Journal of Cardiology.

[221]  M. Satoh,et al.  Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. , 2006, International journal of cardiology.

[222]  E. Verrier,et al.  Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury , 2006, Circulation.

[223]  J. Cigarroa,et al.  CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. , 2011, American journal of physiology. Heart and circulatory physiology.

[224]  P. J. Simpson,et al.  Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. , 1988, The Journal of clinical investigation.

[225]  D. Yellon,et al.  Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium , 2014, Pharmacology & therapeutics.

[226]  Xiao-Fan Wang,et al.  Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction , 2010, Circulation research.

[227]  J. S. Janicki,et al.  Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts , 2011, Hypertension.

[228]  G. Freeman,et al.  Ischemia-Reperfusion of Rat Myocardium Activates Nuclear Factor-&kgr;B and Induces Neutrophil Infiltration Via Lipopolysaccharide-Induced CXC Chemokine , 2001, Circulation.

[229]  A. Hoeft,et al.  Toll-like receptor 4 deficiency: Smaller infarcts, but nogain in function , 2007, BMC physiology.

[230]  N. Voelkel,et al.  The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse , 2011, Proceedings of the National Academy of Sciences.

[231]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[232]  M. Entman,et al.  Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. , 1992, The Journal of clinical investigation.

[233]  M. Entman,et al.  Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration. , 1999, The Journal of clinical investigation.

[234]  GenzouTakemura,et al.  Role of Apoptosis in the Disappearance of Infiltrated and Proliferated Interstitial Cells After Myocardial Infarction , 1998 .

[235]  S. Gerondakis,et al.  Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[236]  M. Entman,et al.  Morphological Characteristics of the Microvasculature in Healing Myocardial Infarcts , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[237]  T. Horie,et al.  Transforming Growth Factor- β1 Induces Phenotypic Modulation of Human Lung Fibroblasts to Myofibroblast Through a c-Jun-NH2-Terminal Kinase-Dependent Pathway , 2001 .

[238]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[239]  Yoshiro Kobayashi.  Neutrophil infiltration and chemokines. , 2006, Critical reviews in immunology.

[240]  G. Christensen,et al.  The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. , 2013, Cardiovascular research.

[241]  G. Angelini,et al.  Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132 , 2011, Circulation research.

[242]  A. Zarbock,et al.  Integrin Regulation during Leukocyte Recruitment , 2013, The Journal of Immunology.

[243]  John Pernow,et al.  Identification and Predictive Value of Interleukin-6+ Interleukin-10+ and Interleukin-6− Interleukin-10+ Cytokine Patterns in ST-Elevation Acute Myocardial Infarction , 2012, Circulation research.

[244]  J. Schaper,et al.  Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.

[245]  A. la Sala,et al.  Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice , 2003, Circulation.

[246]  M. Capogrossi,et al.  HMGB1 Attenuates Cardiac Remodelling in the Failing Heart via Enhanced Cardiac Regeneration and miR-206-Mediated Inhibition of TIMP-3 , 2011, PloS one.

[247]  J. Sluijter,et al.  Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. , 2008, Atherosclerosis.

[248]  N. Frangogiannis,et al.  Cardiovascular , Pulmonary and Renal Pathology CCR 5 Signaling Suppresses Inflammation and Reduces Adverse Remodeling of the Infarcted Heart , Mediating Recruitment of Regulatory T Cells , 2010 .

[249]  F. Prósper,et al.  Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. , 2015, Journal of the American College of Cardiology.

[250]  A. Reddy,et al.  Systematic Characterization of Myocardial Inflammation, Repair, and Remodeling in a Mouse Model of Reperfused Myocardial Infarction , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[251]  G. Booz,et al.  Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. , 1995, Cardiovascular research.

[252]  P. Libby,et al.  Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. , 2010, Journal of the American College of Cardiology.

[253]  M. Entman,et al.  Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. , 2004, The American journal of pathology.

[254]  A. Itai,et al.  Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. , 2004, Cardiovascular research.

[255]  A. Ganser,et al.  Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction , 2015, Nature Medicine.

[256]  H. Methe,et al.  Expansion of Circulating Toll-Like Receptor 4–Positive Monocytes in Patients With Acute Coronary Syndrome , 2005, Circulation.

[257]  A. J. Valente,et al.  Interleukin‐18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K‐Akt‐dependent NF‐κB activation , 2008, Journal of cellular physiology.

[258]  G. Ertl,et al.  Foxp3+ CD4+ T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation , 2014, Circulation research.

[259]  Masafumi Takahashi,et al.  MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species. , 2008, Cardiovascular research.

[260]  J. Stockand,et al.  Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. , 2003, American journal of physiology. Heart and circulatory physiology.

[261]  M. Baggiolini,et al.  Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils , 1990, The Journal of experimental medicine.

[262]  M. Entman,et al.  Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts , 2005, Circulation.

[263]  S. Prabhu.  Takes Two to Tango : Monocyte and Macrophage Duality in the Infarcted Heart , 2014 .

[264]  P. Carmeliet,et al.  Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction , 2009, The Journal of experimental medicine.

[265]  Bernd Nilius,et al.  TRP Channels in Disease , 2005, Science's STKE.

[266]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[267]  C. Serhan,et al.  Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. , 2015, Journal of molecular and cellular cardiology.

[268]  P. Bruneval,et al.  TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction. , 2015, Circulation research.

[269]  C. Scheiermann,et al.  Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils , 2006, The Journal of experimental medicine.

[270]  I. Komuro,et al.  Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis After Myocardial Infarction , 2010, Circulation.

[271]  M. Harmsen,et al.  Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[272]  Zhonglin Xie,et al.  Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin , 2001, Circulation research.

[273]  林丽,et al.  Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction , 2015 .

[274]  Xiao-Fan Wang,et al.  Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice , 2015, Circulation. Heart failure.